BioGeneration Ventures Investments & Fund Profile

Overview

Investing in early-stage life sciences companies in the Netherlands.

Founded

2006

Deals · 12mo

3

Links

Website LinkedIn X (Twitter)

Stage focus

Seed

Series A

Series B

Geographic focus

Belgium

Germany

The Netherlands

United Kingdom

...

Sector focus

Financial Services

Life Science

Venture Capital

Investment portfolio

34rounds

LedParticipated

NAME	DATE	SIZE
Rouge Therapeutics	Oct 2026Led	$58 MSeries A
Mironid	Aug 2026Participated	$46 MSeries B
TargED Biopharmaceuticals	Dec 2025Led	$25 MSeries A
Azafaros	May 2025Participated	$155 MSeries B
Avidicure	Apr 2025Participated	$50 MSeed
RhyGaze	Jan 2025Participated	$86 MSeries A
Citryll	Dec 2024Participated	$99 MSeries B
Kivu Bioscience	Oct 2024Participated	$92 MSeries A
Confo Therapeutics	Jul 2024Participated	$65 MSeries B
VectorY	Nov 2023Participated	$138 MSeries A
Artica Therapeutics	Nov 2023Participated	$13 MSeed
Tessellate BIO	Oct 2023Led	$8 MSeed
Rouge Therapeutics	Oct 2026Led	$58 MSeries A
Mironid	Aug 2026Participated	$46 MSeries B
TargED Biopharmaceuticals	Dec 2025Led	$25 MSeries A
Azafaros	May 2025Participated	$155 MSeries B
Avidicure	Apr 2025Participated	$50 MSeed
RhyGaze	Jan 2025Participated	$86 MSeries A
Citryll	Dec 2024Participated	$99 MSeries B
Kivu Bioscience	Oct 2024Participated	$92 MSeries A
Confo Therapeutics	Jul 2024Participated	$65 MSeries B
VectorY	Nov 2023Participated	$138 MSeries A
Artica Therapeutics	Nov 2023Participated	$13 MSeed
Tessellate BIO	Oct 2023Led	$8 MSeed

34 Items

34

Items

...

Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

BioGeneration Ventures: 34 funding rounds are recorded in the selected participation categories. All available history
Round type	Led deals	Participated deals
Seed	3	3
Series A	6	7
Series B	0	10
Series C+	0	1
Other Equity	2	2

Monthly Deal Activity

BioGeneration Ventures: 34 deals are recorded across 206 months. All available history
Month	Deals
Sep '09	1
Oct '09	0
Nov '09	0
Dec '09	0
Jan '10	0
Feb '10	0
Mar '10	0
Apr '10	0
May '10	0
Jun '10	0
Jul '10	0
Aug '10	0
Sep '10	0
Oct '10	0
Nov '10	0
Dec '10	0
Jan '11	0
Feb '11	0
Mar '11	0
Apr '11	0
May '11	0
Jun '11	0
Jul '11	0
Aug '11	0
Sep '11	0
Oct '11	0
Nov '11	0
Dec '11	1
Jan '12	0
Feb '12	0
Mar '12	0
Apr '12	0
May '12	0
Jun '12	0
Jul '12	0
Aug '12	0
Sep '12	0
Oct '12	0
Nov '12	1
Dec '12	0
Jan '13	0
Feb '13	0
Mar '13	0
Apr '13	0
May '13	0
Jun '13	0
Jul '13	0
Aug '13	0
Sep '13	0
Oct '13	0
Nov '13	0
Dec '13	0
Jan '14	0
Feb '14	0
Mar '14	0
Apr '14	0
May '14	0
Jun '14	0
Jul '14	0
Aug '14	0
Sep '14	0
Oct '14	0
Nov '14	0
Dec '14	1
Jan '15	0
Feb '15	0
Mar '15	0
Apr '15	0
May '15	0
Jun '15	0
Jul '15	0
Aug '15	0
Sep '15	0
Oct '15	0
Nov '15	0
Dec '15	0
Jan '16	0
Feb '16	0
Mar '16	0
Apr '16	0
May '16	0
Jun '16	0
Jul '16	0
Aug '16	0
Sep '16	0
Oct '16	0
Nov '16	0
Dec '16	0
Jan '17	1
Feb '17	0
Mar '17	0
Apr '17	0
May '17	0
Jun '17	0
Jul '17	1
Aug '17	0
Sep '17	0
Oct '17	1
Nov '17	0
Dec '17	0
Jan '18	0
Feb '18	0
Mar '18	1
Apr '18	0
May '18	0
Jun '18	0
Jul '18	1
Aug '18	0
Sep '18	0
Oct '18	0
Nov '18	0
Dec '18	0
Jan '19	0
Feb '19	0
Mar '19	0
Apr '19	0
May '19	1
Jun '19	0
Jul '19	0
Aug '19	0
Sep '19	0
Oct '19	0
Nov '19	0
Dec '19	0
Jan '20	1
Feb '20	1
Mar '20	0
Apr '20	0
May '20	0
Jun '20	0
Jul '20	2
Aug '20	0
Sep '20	0
Oct '20	0
Nov '20	1
Dec '20	0
Jan '21	0
Feb '21	0
Mar '21	0
Apr '21	0
May '21	0
Jun '21	1
Jul '21	0
Aug '21	0
Sep '21	0
Oct '21	0
Nov '21	0
Dec '21	0
Jan '22	0
Feb '22	1
Mar '22	1
Apr '22	0
May '22	0
Jun '22	0
Jul '22	0
Aug '22	0
Sep '22	0
Oct '22	0
Nov '22	2
Dec '22	0
Jan '23	0
Feb '23	0
Mar '23	0
Apr '23	1
May '23	1
Jun '23	0
Jul '23	0
Aug '23	0
Sep '23	0
Oct '23	1
Nov '23	2
Dec '23	0
Jan '24	0
Feb '24	0
Mar '24	0
Apr '24	0
May '24	0
Jun '24	0
Jul '24	1
Aug '24	0
Sep '24	0
Oct '24	1
Nov '24	0
Dec '24	1
Jan '25	1
Feb '25	0
Mar '25	0
Apr '25	1
May '25	1
Jun '25	0
Jul '25	0
Aug '25	0
Sep '25	0
Oct '25	0
Nov '25	0
Dec '25	1
Jan '26	0
Feb '26	0
Mar '26	0
Apr '26	0
May '26	0
Jun '26	0
Jul '26	0
Aug '26	1
Sep '26	0
Oct '26	1

Sector Breakdown

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

BioGeneration Ventures: Health & Life Sciences is the largest displayed sector by deal count (34 deals). All available history
Sector	Deals
Health & Life Sciences	34
Manufacturing	4
Space & Frontier Tech	4
Social & Community Platforms	2
Consumer & Lifestyle	1

Deal Size Distribution

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

BioGeneration Ventures: 34 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)	Deals
<$5M	0
$5M-$10M	6
$10M-$25M	7
$25M-$50M	10
$50M-$100M	9
$100M-$250M	2
$250M-$500M	0
$500M-$1B	0
$1B+	0

Deals By Geography

Top 2 of 2 regions; European countries are grouped as Europe.

BioGeneration Ventures: Europe has the largest recorded deal count among the displayed regions (30 deals). All available history
Region	Deals
Europe	30
United States	4

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

BioGeneration Ventures: 20 co-investors are shown, with Forbion sharing 14 recorded deals. All available history
Co-investor	Shared deals
Forbion	14
BOM	6
EQT Life Sciences (LSP)	6
INKEF Capital	6
Thuja Capital	6
InnovationQuarter	4
Novartis	4
Vesalius Biocapital	4
Curie Capital	3
Fund+	3
Seroba Life Sciences	3
Seventure Partners	3
V-Bio Ventures	3
VIB	3
BioMedPartners	2
Chemelot Ventures	2
coparion	2
Epidarex Capital	2
Gimv	2
Hadean Ventures	2